Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05635617 · ClinicalTrials.gov registry record
SFDI in High Energy Lower Extremity Fracture
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 56
- Enrollment target
NCT05635617: Completed study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT05635617 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05635617 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
This is a non-randomized prospective study of 20 patients with high energy lower extremity fractures evaluating feasibility and acceptability of SFDI, a real-time optical imaging technology.
Primary Outcome
The long-term objective for this research is to determine whether objective measures of perfusion through SFDI can be a predictive tool used in the ED, clinic or the operating room to determining when high-energy lower extremity fractures can safely undergo surgical fixation.
Interventions
- PROCEDURE Lower Extremity Surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2025-03-24 |
What the finished NCT05635617 record still lists
NCT05635617 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Lower Extremity Surgery is the first listed.
NCT05635617 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05635617 about?
NCT05635617 is a clinical study titled "SFDI in High Energy Lower Extremity Fracture". This is a non-randomized prospective study of 20 patients with high energy lower extremity fractures evaluating feasibility and acceptability of SFDI, a real-time optical imaging technology.
What is the current status of trial NCT05635617?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2022-08-15. Estimated completion is 2025-03-24.
What interventions are being tested in trial NCT05635617?
The interventions under investigation include: Lower Extremity Surgery (PROCEDURE).
Who is sponsoring clinical trial NCT05635617?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI